CRONOS GROUP INC. Payments to Acquire Marketable Securities
CRONOS GROUP INC. (CRON) reported Payments to Acquire Marketable Securities of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2024-11-12
- CRONOS GROUP INC. payments to acquire marketable securities for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. payments to acquire marketable securities for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. payments to acquire marketable securities for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CRONOS GROUP INC. payments to acquire marketable securities for the quarter ending 2023-09-30 was $57.42M, a 51.37% decline year-over-year.
- CRONOS GROUP INC. payments to acquire marketable securities for fiscal 2019 was $299.92M.
- CRONOS GROUP INC. payments to acquire marketable securities for fiscal 2018 was $0.00.
- CRONOS GROUP INC. payments to acquire marketable securities for fiscal 2017 was $0.00.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 6 month as first filed | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | ||||
| 2023-09-30 | $57.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $114.57M derived: sum of 2 quarters · filed 2024-11-12 | $537.19M 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $57.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $479.76M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $422.61M 10-Q · filed 2024-05-09 | ||||
| 2022-09-30 | $118.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $275.37M derived: sum of 2 quarters · filed 2023-11-08 | $275.37M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $157.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $157.30M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | ||||
| 2021-09-30 | -$360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $119.82M 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $120.18M 10-Q · filed 2022-08-09 | ||||
| 2020-09-30 | -$74.61M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18 | -$952.00K derived: sum of 2 quarters · filed 2022-02-18 | $125.56M 10-Q · filed 2022-02-18 | $41.20M derived: sum of 4 quarters · filed 2022-02-18 | |
| 2020-06-30 | $73.66M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18 | $200.17M 10-Q/A · filed 2022-02-18 | $124.58M 10-Q · filed 2020-08-06 | $115.81M derived: sum of 3 quarters · filed 2022-02-18 | -$56.78M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | $126.51M 10-Q · filed 2020-05-08 | $42.15M derived: sum of 2 quarters · filed 2021-02-26 | -$130.44M derived: sum of 3 quarters · filed 2021-02-26 | $426.44M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-12-31 | -$84.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$256.95M derived: sum of 2 quarters · filed 2021-02-26 | $299.92M derived: sum of 3 quarters · filed 2021-02-26 | $299.92M 10-K · filed 2021-02-26 | |
| 2019-09-30 | -$172.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $384.29M derived: sum of 2 quarters · filed 2020-11-05 | $384.29M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $556.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $556.88M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 | ||||
| 2017-12-31 | $0.00 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |